Cargando…

Attainment of Lipid Targets Following Coronary Artery Bypass Graft Surgery: Can We Do Better?

OBJECTIVE: Patients undergoing coronary artery bypass graft (CABG) surgery remain at high cardiovascular risk; however, few studies have evaluated lipid management and attainment of lipid targets in these patients. We investigated the proportion of CABG surgery patients who attained low-density lipo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Nick S. R., Ali, Umar S., Yeap, Bu B., Fegan, P. Gerry, Larbalestier, Robert, Bell, Damon A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Lipidology and Atherosclerosis 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133779/ https://www.ncbi.nlm.nih.gov/pubmed/35656149 http://dx.doi.org/10.12997/jla.2022.11.2.187

Ejemplares similares

The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions
por: Lan, Nick S.R., et al.
Publicado: (2019)

Totally robotic sutured coronary artery bypass grafting: How we do it
por: Torregrossa, Gianluca, et al.
Publicado: (2020)

Coronary Artery Bypass Grafting in Acute Ischemic Heart Failure: Where do We Stand? (And Where Should We Go?)
por: Kubrusly, Fernando B., et al.
Publicado: (2018)

Complete revascularization in coronary artery bypass grafting: How sure are we?
por: Zhou, Zhuoming, et al.
Publicado: (2021)

Malaria: How Are We Doing and How Can We Do Better?
por: Rosenthal, Philip J., et al.
Publicado: (2019)

Occluded mammary graft post-coronary bypass surgery: do we need to look for the second one? A case report
por: Yalonetsky, Sergey, et al.
Publicado: (2019)

Superior epigastric artery pseudoaneurysm- a rare complication of chest drain insertion in coronary artery bypass grafting
por: Sadat, Umar, et al.
Publicado: (2007)

Osteoarthritis: Can We Do Better?
por: Collins, Dylon P, et al.
Publicado: (2022)

Coronary artery bypass grafting in the octogenarians: should we intervene, or leave them be?
por: Ozen, Anil, et al.
Publicado: (2015)

Reply: Valveless saphenous vein grafts for coronary artery bypass grafting: First, do no harm
por: Shapira, Oz M.
Publicado: (2021)

Doing what we do best, only better
por: Nunnari, Jodi, et al.
Publicado: (2016)

Prognostic significance of positive family history in outcomes after coronary artery bypass grafting: Do we need to update our assumptions?
por: Tavolinejad, Hamed, et al.
Publicado: (2022)

Rationing care in COVID-19: if we must do it, can we do better?
por: Rockwood, Kenneth
Publicado: (2020)

Gallbladder Cancer: We Need to Do Better!
por: Shukla, Parul J., et al.
Publicado: (2009)

Pharmacy Internships: We Can Do Better
por: Nisly, Sarah, et al.
Publicado: (2018)

Innovation in Gastroenterology—Can We Do Better?
por: Klang, Eyal, et al.
Publicado: (2022)

We can do much better than what we did
por: Lee, Sang-Hak
Publicado: (2020)

Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
por: Shi, Chunxia, et al.
Publicado: (2022)

What Do We Need to Do for Better Casualty Support in Disasters?
por: Nekooei Moghadam, M, et al.
Publicado: (2011)

Graves' Disease Presenting with Periodic Paralysis to the Emergency Department
por: Lan, Nick Si Rui, et al.
Publicado: (2018)

Myocardial infarction on the ICU: can we do better?
por: Webb, Ian, et al.
Publicado: (2008)

Diagnosis of latent tuberculosis: Can we do better?
por: Al-Orainey, Ibrahim O.
Publicado: (2009)

Do we need better hepatitis B vaccines?
por: Gerlich, Wolfram H.
Publicado: (2017)

Sebaceous gland carcinoma: Can we do better?
por: Honavar, Santosh G
Publicado: (2018)

Terminal Care: How Can We Do Better?
por: Wilkes, Erik
Publicado: (1986)

Oral cancer: We can do better - now
Publicado: (2020)

Cancer in southeast Asia: can we do better?
por: The Lancet Regional Health – Southeast Asia
Publicado: (2023)

Arterial bypass grafting of the coronary circulation
por: Parsa, C J, et al.
Publicado: (2011)

Conduits for Coronary Bypass: Vein Grafts
por: Barner, Hendrick B, et al.
Publicado: (2012)

Outcome and Graft Patency in Coronary Artery Bypass Grafting with Coronary Endarterectomy
por: Nemati, Mohammad Hassan, et al.
Publicado: (2015)

Clinical consequences of poor adherence to lipid-lowering therapy in patients with cardiovascular disease: can we do better?
por: Klimis, Harry, et al.
Publicado: (2019)

Premature Coronary Heart Disease and Traditional Risk Factors-Can We Do Better?
por: Sadeghi, Roxana, et al.
Publicado: (2013)

Commentary: Postcoronary artery bypass grafting treatment of dyslipidemia: Better hit those targets!
por: Ben Ali, Walid, et al.
Publicado: (2022)

Comparison of percutaneous coronary intervention of native coronary artery versus bypass graft in patients with prior coronary artery bypass grafting
por: Yang, Zhiqiang, et al.
Publicado: (2023)

Is Lower Better?: HbA1c Level Is Associated With Venous Graft Patency Following Coronary Bypass Surgery
por: Gaudino, Mario, et al.
Publicado: (2022)

Preventing graft restenosis after coronary artery bypass grafting with tissue-type plasminogen activator
por: Li, Ruixiong, et al.
Publicado: (2017)

Factors associated with lipid goal attainment among acute coronary syndrome patients
por: Mohd-Zulkefli, Siti-Zainora, et al.
Publicado: (2016)

Pain management following laparoscopy: Can we do better?
por: Tobias, Joseph D.
Publicado: (2013)

Labor pain relief for parturients: We can do better
por: Wang, Xian, et al.
Publicado: (2014)

Labor pain relief for parturients: We can do better
por: Wang, Xian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u9gdf3ga33e154a45imtjq1617